Reference 46 in the bibliography for DOI: 10.3390/pathogens9020148 (Q8033)
Revision as of 18:45, 14 April 2020 by Admin (talk | contribs) (Created claim: Property:P93: Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants, #quickstatements; #temporary_batch_1586889893706)
Publication: "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development" in the MDPI journal Pathogens (2020); DOI: 10.3390/pathogens9020148
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Reference 46 in the bibliography for DOI: 10.3390/pathogens9020148
|
Publication: "Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development" in the MDPI journal Pathogens (2020); DOI: 10.3390/pathogens9020148
|
Statements
Regulatory approval and a first-in-human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants (English)
0 references
